Navigation Links
ISTO Technologies to Present at OneMedPlace Emerging Company Finance Conference

ST. LOUIS, Jan. 6 /PRNewswire/ -- ISTO Technologies, Inc. announced today that it will participate in the 2nd Annual OneMedPlace Emerging Company Finance Conference in San Francisco, CA from January 13-14, 2009. Mitchell Seyedin, Ph. D., President and CEO of ISTO, will present on Tuesday, January 13th at 10:15 a.m. Pacific Time, at the Sir Francis Drake Hotel at 450 Powell St. The conference will bring together promising emerging healthcare and life science companies with strategic and venture investors focused on new technologies, emerging and micro cap public companies. Information about OneMedPlace and the conference may be found at

ISTO is a privately-held orthobiologics company based in St. Louis, MO. The Company's discrete cell-based and biomaterial platforms encompass a number of technological breakthroughs that are poised to advance the practice of medicine by offering solutions for unmet and/or largely unsatisfied clinical needs in large orthopedic markets. ISTO's mix of clinical stage, development stage and marketed products includes DeNovo(R) ET, engineered cartilage to repair and restore joint function in the knee, NuQu(TM), a cell-based injectable formulation of juvenile chondrocytes for nucleus regeneration of the spinal disc and InQu(R), an osteobiologic bone graft Substitute and extender.

About ISTO

ISTO Technologies, Inc. is developing and marketing clinical solutions for sports medicine, spinal therapy, and trauma. ISTO's products are intended for the repair and regeneration of damaged or injured cartilage and bone. For additional information on ISTO, please visit our website at or contact Scott Gill, Chief Financial Officer, at +1-314-995-6049.

SOURCE ISTO Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. BioSpecifics Technologies Corp. Announces Listing on NASDAQ Global Market
2. BioStorage Technologies Partners with Susan G. Komen for the Cure(R) Tissue Bank at the IU Simon Cancer Center in Breast Cancer Research Initiative
3. RainDance Technologies and Harvard University to Share in First Massachusetts Life Sciences Center Cooperative Research Grants
4. Palatin Technologies Receives Notification Letter from NYSE Alternext US
5. GlaxoSmithKline Reduces Minimum Tender Condition and Extends Tender Offer To Acquire Genelabs Technologies, Inc.
6. Neurobiological Technologies Partner, Celtic Pharma, Provides Update on XERECEPT(R) Clinical Program and Planned Sale in 2009
7. Cascades Technologies, Inc. and SAIC Team on $19 Million Contract with National Institutes of Health
8. Life Science Alley: R&D Makes German Medical Technologies Top in Europe
9. GlaxoSmithKline Extends Tender Offer for Genelabs Technologies, Inc.
10. GlaxoSmithKline Announces Waiver of a Condition to the Tender Offer for Genelabs Technologies, Inc.
11. Sigma-Aldrich Signs Agreement With SouthWest NanoTechnologies to Distribute SWeNT(R) Single-Wall Carbon Nanotubes
Post Your Comments:
(Date:11/24/2015)... , ... November 24, 2015 , ... Whitehouse Laboratories is ... The new stand-alone facility will be strictly dedicated to basic USP 61, USP ... existing clients the chance to have complete chemistry and micro testing performed by one ...
(Date:11/23/2015)...   Ceres, Inc . (Nasdaq: CERE ), ... the fiscal year ended August 31, 2015 and provided ... --> During fiscal year 2015, Ceres ... with a better balance of yield, energy and nutrition. ... several leading crop input providers and made significant progress ...
(Date:11/23/2015)... ... November 23, 2015 , ... Noblis, Inc., a leading provider of science, ... Programs, National Geospatial Intelligence Agency (NGA), has joined the Noblis NSP team as President ... in the intelligence community and the private sector,” said L. Roger Mason, Jr., ...
(Date:11/23/2015)... , November 23, 2015 ... $4.27 million in 2015, and it is expected to ... 2023. The factors driving the growth of the global ... carbon sequestration property of biochar, increased government initiatives and ... government initiatives and stringent environment regulations are the key ...
Breaking Biology Technology:
(Date:11/11/2015)... MINNETONKA, Minn. , Nov. 11, 2015   MedNet ... the entire spectrum of clinical research, is pleased to announce ... Partnerships in Clinical Trials (PCT) event, to be held ... will be able to view live demonstrations of ... platform, and learn how iMedNet has been able ...
(Date:11/9/2015)... DUBLIN , Nov. 09, 2015 /PRNewswire/ ... announced the addition of the "Global ... to their offering. --> ... "Global Law Enforcement Biometrics Market 2015-2019" ... Research and Markets ( ) ...
(Date:11/2/2015)... PARK, Calif. , Nov. 2, 2015  SRI ... $9 million to provide preclinical development services to the ... the contract, SRI will provide scientific expertise, modern testing ... wide variety of preclinical pharmacology and toxicology studies to ... --> The PREVENT Cancer Drug Development ...
Breaking Biology News(10 mins):